{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:53:53Z","timestamp":1790387633181,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,30]]},"DOI":"10.7759\/cureus.42706","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T05:19:15Z","timestamp":1690780755000},"source":"Crossref","is-referenced-by-count":2,"title":["Hereditary Hemorrhagic Telangiectasia With Multiple Ear, Nose, and Throat (ENT) Manifestations: A Case Report"],"prefix":"10.7759","author":[{"given":"Eleni","family":"Litsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lentiona","family":"Basiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsirves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios V","family":"Psychogios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan ME","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, et al.. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011, 48:73-87. 10.1136\/jmg.2009.069013","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan ME","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, et al.. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020, 173:989-1001. 10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin CL","year":"2010","unstructured":"Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24:203-19. 10.1016\/j.blre.2010.07.001","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320320302","article-title":"Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population","volume":"32","author":"Plauchu H","year":"1989","unstructured":"Plauchu H, de Chadar\u00e9vian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989, 32:291-7. 10.1002\/ajmg.1320320302","journal-title":"Am J Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23893","article-title":"Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia","volume":"123","author":"Silva BM","year":"2013","unstructured":"Silva BM, Hosman AE, Devlin HL, Shovlin CL. Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia. Laryngoscope. 2013, 123:1092-9. 10.1002\/lary.23893","journal-title":"Laryngoscope"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9421","article-title":"Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients","volume":"27","author":"Lesca G","year":"2006","unstructured":"Lesca G, Burnichon N, Raux G, et al.. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Hum Mutat. 2006, 27:598. 10.1002\/humu.9421","journal-title":"Hum Mutat"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1177\/194589240602000116","article-title":"New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia","volume":"20","author":"Mahoney EJ","year":"2006","unstructured":"Mahoney EJ, Shapshay SM. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Am J Rhinol. 2006, 20:87-90.","journal-title":"Am J Rhinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21328","article-title":"Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"4","author":"Luk L","year":"2014","unstructured":"Luk L, Mace JC, Bhandarkar ND, Sautter NB. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Int Forum Allergy Rhinol. 2014, 4:640-5. 10.1002\/alr.21328","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag JB","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010, 120:838-43. 10.1002\/lary.20818","journal-title":"Laryngoscope"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-06701-z","article-title":"Long-term efficacy assessment of current treatment options for epistaxis in HHT","volume":"278","author":"D\u00fcr C","year":"2021","unstructured":"D\u00fcr C, Anschuetz L, Negoias S, Bulut OC, Angelillo-Scherrer A, Caversaccio M. Long-term efficacy assessment of current treatment options for epistaxis in HHT. Eur Arch Otorhinolaryngol. 2021, 278:4321-8. 10.1007\/s00405-021-06701-z","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard S","year":"2014","unstructured":"Gaillard S, Dupuis-Girod S, Boutitie F, et al.. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost. 2014, 12:1494-502. 10.1111\/jth.12654","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-07-0425","article-title":"Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells","volume":"103","author":"Albi\u00f1ana V","year":"2010","unstructured":"Albi\u00f1ana V, Bernabeu-Herrero ME, Zarrabeitia R, Bernab\u00e9u C, Botella LM. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Thromb Haemost. 2010, 103:441-51. 10.1160\/TH09-07-0425","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-03-0239","article-title":"Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia","volume":"115","author":"Zarrabeitia R","year":"2016","unstructured":"Zarrabeitia R, Ojeda-Fernandez L, Recio L, Bernab\u00e9u C, Parra JA, Albi\u00f1ana V, Botella LM. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia. Thromb Haemost. 2016, 115:1167-77. 10.1160\/TH15-03-0239","journal-title":"Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.067447","article-title":"Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-\u03b21 signaling in endothelial cells","volume":"79","author":"Albi\u00f1ana V","year":"2011","unstructured":"Albi\u00f1ana V, Sanz-Rodr\u00edguez F, Recio-Poveda L, Bernab\u00e9u C, Botella LM. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-\u03b21 signaling in endothelial cells. Mol Pharmacol. 2011, 79:833-43. 10.1124\/mol.110.067447","journal-title":"Mol Pharmacol"},{"key":"ref15","article-title":"Atorvastatin induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin","volume":"66","author":"Zemankova L","year":"2015","unstructured":"Zemankova L, Varejckova M, Dolezalova E, et al.. Atorvastatin induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin. J Physiol Pharmacol. 2015, 66:403-13.","journal-title":"J Physiol Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod S","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin JC, et al.. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012, 307:948-55. 10.1001\/jama.2012.250","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v8.i12.792","article-title":"Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia","volume":"8","author":"Ou G","year":"2016","unstructured":"Ou G, Galorport C, Enns R. Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. World J Gastrointest Surg. 2016, 8:792-5. 10.4240\/wjgs.v8.i12.792","journal-title":"World J Gastrointest Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11387","article-title":"Effect of bevacizumab nasal spray on epistaxis duration in hereditary hemorrhagic telangectasia: a randomized clinical trial","volume":"316","author":"Dupuis-Girod S","year":"2016","unstructured":"Dupuis-Girod S, Ambrun A, Decullier E, et al.. Effect of bevacizumab nasal spray on epistaxis duration in hereditary hemorrhagic telangectasia: a randomized clinical trial. JAMA. 2016, 316:934-42. 10.1001\/jama.2016.11387","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin F","year":"2010","unstructured":"Lebrin F, Srun S, Raymond K, et al.. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med. 2010, 16:420-8. 10.1038\/nm.2131","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-11-0809","article-title":"Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia","volume":"108","author":"Albi\u00f1ana V","year":"2012","unstructured":"Albi\u00f1ana V, Recio-Poveda L, Zarrabeitia R, Bernab\u00e9u C, Botella LM. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia. Thromb Haemost. 2012, 108:41-53. 10.1160\/TH11-11-0809","journal-title":"Thromb Haemost"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15715","article-title":"A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies","volume":"20","author":"Al-Samkari H","year":"2022","unstructured":"Al-Samkari H, Eng W. A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies. J Thromb Haemost. 2022, 20:1077-88. 10.1111\/jth.15715","journal-title":"J Thromb Haemost"},{"key":"ref22","article-title":"The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study","volume":"47","author":"de Gussem EM","year":"2009","unstructured":"de Gussem EM, Snijder RJ, Disch FJ, Zanen P, Westermann CJ, Mager JJ. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study. Rhinology. 2009, 47:85-8.","journal-title":"Rhinology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11724","article-title":"Effect of topical intranasal therapy on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia: a randomized clinical trial","volume":"316","author":"Whitehead KJ","year":"2016","unstructured":"Whitehead KJ, Sautter NB, McWilliams JP, et al.. Effect of topical intranasal therapy on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia: a randomized clinical trial. JAMA. 2016, 316:943-51. 10.1001\/jama.2016.11724","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1977.00780280027001","article-title":"Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases","volume":"103","author":"McCaffrey TV","year":"1977","unstructured":"McCaffrey TV, Kern EB, Lake CF. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol. 1977, 103:627-30. 10.1001\/archotol.1977.00780280027001","journal-title":"Arch Otolaryngol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.12.019","article-title":"The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia","volume":"134","author":"Ghaheri BA","year":"2006","unstructured":"Ghaheri BA, Fong KJ, Hwang PH. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2006, 134:1006-9. 10.1016\/j.otohns.2005.12.019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215111001733","article-title":"Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series","volume":"125","author":"Joshi H","year":"2011","unstructured":"Joshi H, Woodworth BA, Carney AS. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series. J Laryngol Otol. 2011, 125:1176-80. 10.1017\/S0022215111001733","journal-title":"J Laryngol Otol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-011-1677-9","article-title":"Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia","volume":"268","author":"J\u00f8rgensen G","year":"2011","unstructured":"J\u00f8rgensen G, Lange B, Wanscher JH, Kjeldsen AD. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia. Eur Arch Otorhinolaryngol. 2011, 268:1765-70. 10.1007\/s00405-011-1677-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.1900160303","article-title":"Laser safety","volume":"16","author":"Sliney DH","year":"1995","unstructured":"Sliney DH. Laser safety. Lasers Surg Med. 1995, 16:215-25. 10.1002\/lsm.1900160303","journal-title":"Lasers Surg Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23147","article-title":"Laser-assisted control of epistaxis in hereditary hemorrhagic telangiectasia: a systematic review","volume":"52","author":"Abiri A","year":"2020","unstructured":"Abiri A, Goshtasbi K, Maducdoc M, Sahyouni R, Wang MB, Kuan EC. Laser-assisted control of epistaxis in hereditary hemorrhagic telangiectasia: a systematic review. Lasers Surg Med. 2020, 52:293-300. 10.1002\/lsm.23147","journal-title":"Lasers Surg Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.14639\/0392-100X-N0915","article-title":"Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience","volume":"41","author":"Pagella F","year":"2021","unstructured":"Pagella F, Pusateri A, Maiorano E, et al.. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience. Acta Otorhinolaryngol Ital. 2021, 41:59-68. 10.14639\/0392-100X-N0915","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199901000-00004","article-title":"Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia","volume":"109","author":"Bergler W","year":"1999","unstructured":"Bergler W, Riedel F, Baker-Schreyer A, Juncker C, H\u00f6rmann K. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope. 1999, 109:15-20. 10.1097\/00005537-199901000-00004","journal-title":"Laryngoscope"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1258\/ar.2011.110132","article-title":"Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization","volume":"52","author":"Trojanowski P","year":"2011","unstructured":"Trojanowski P, Jargiello T, Trojanowska A, Klatka J. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization. Acta Radiol. 2011, 52:846-9. 10.1258\/ar.2011.110132","journal-title":"Acta Radiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21484","article-title":"Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia","volume":"5","author":"Boyer H","year":"2015","unstructured":"Boyer H, Fernandes P, Le C, Yueh B. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia. Int Forum Allergy Rhinol. 2015, 5:435-40. 10.1002\/alr.21484","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino11.142","article-title":"Local sclerotherapy with polydocanol (Aethoxysklerol\u00ae) for the treatment of Epistaxis in Rendu-Osler-Weber or hereditary hemorrhagic telangiectasia (HHT): 15 years of experience","volume":"50","author":"Morais D","year":"2012","unstructured":"Morais D, Mill\u00e1s T, Zarrabeitia R, Botella LM, Almaraz A. Local sclerotherapy with polydocanol (Aethoxysklerol\u00ae) for the treatment of Epistaxis in Rendu-Osler-Weber or hereditary hemorrhagic telangiectasia (HHT): 15 years of experience. Rhinology. 2012, 50:80-6. 10.4193\/Rhino11.142","journal-title":"Rhinology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21287","article-title":"Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu)","volume":"4","author":"Hanks JE","year":"2014","unstructured":"Hanks JE, Hunter D, Goding GS Jr, Boyer HC. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu). Int Forum Allergy Rhinol. 2014, 4:422-7. 10.1002\/alr.21287","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000000453","article-title":"Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia","volume":"25","author":"Kim JY","year":"2014","unstructured":"Kim JY, Oh JH, Kim GT, Kwon JH. Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia. J Craniofac Surg. 2014, 25:e120-2. 10.1097\/SCS.0000000000000453","journal-title":"J Craniofac Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2008.22.3145","article-title":"The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"22","author":"Harvey RJ","year":"2008","unstructured":"Harvey RJ, Kanagalingam J, Lund VJ. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis. Am J Rhinol. 2008, 22:182-7. 10.2500\/ajr.2008.22.3145","journal-title":"Am J Rhinol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.01.005","article-title":"Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia","volume":"138","author":"Levine CG","year":"2008","unstructured":"Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2008, 138:721-4. 10.1016\/j.otohns.2008.01.005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2007.21.3017","article-title":"Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation","volume":"21","author":"Lesnik GT","year":"2007","unstructured":"Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI Jr. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Am J Rhinol. 2007, 21:312-5. 10.2500\/ajr.2007.21.3017","journal-title":"Am J Rhinol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05758-1","article-title":"Patient-recorded benefit from nasal closure in a Danish cohort of patients with hereditary haemorrhagic telangiectasia","volume":"277","author":"Andersen JH","year":"2020","unstructured":"Andersen JH, Kjeldsen AD. Patient-recorded benefit from nasal closure in a Danish cohort of patients with hereditary haemorrhagic telangiectasia. Eur Arch Otorhinolaryngol. 2020, 277:791-800. 10.1007\/s00405-019-05758-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204720","article-title":"Hereditary hemorrhagic telangiectasia: success of the Osler calendar for documentation of treatment and course of disease","volume":"10","author":"Seebauer CT","year":"2021","unstructured":"Seebauer CT, Freigang V, Schwan FE, Fischer R, Bohr C, K\u00fchnel TS, Andorfer KE. Hereditary hemorrhagic telangiectasia: success of the Osler calendar for documentation of treatment and course of disease. J Clin Med. 2021, 10:4720. 10.3390\/jcm10204720","journal-title":"J Clin Med"},{"key":"ref42","article-title":"Osler-Weber-Rendu disease","author":"Macri A","year":"2023","unstructured":"Macri A, Wilson AM, Shafaat O, Sharma S. Osler-Weber-Rendu disease. StatPearls. StatPearls Publishing, Treasure Island (FL); 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172371-hereditary-hemorrhagic-telangiectasia-with-multiple-ear-nose-and-throat-ent-manifestations-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:02Z","timestamp":1707508982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172371-hereditary-hemorrhagic-telangiectasia-with-multiple-ear-nose-and-throat-ent-manifestations-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,30]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.42706","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,30]]}}}